JEANNA CHAPMAN: Open Payments
NPI 1255897815 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,140 in 81 payments from 19 companies in 2025. Trend: 2023 $864 · 2024 $1,995 · 2025 $2,140
Food & beverage: $2,075Education: $65
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $281 |
| United Therapeutics Corporation | 9 | $277 |
| GlaxoSmithKline, LLC. | 14 | $266 |
| GENZYME CORPORATION | 8 | $254 |
| Actelion Pharmaceuticals US, Inc. | 8 | $241 |
| Regeneron Healthcare Solutions, Inc. | 8 | $182 |
| Insmed, Inc. | 6 | $127 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $118 |
| Merck Sharp & Dohme LLC | 2 | $113 |
| Viatris Specialty LLC | 2 | $52 |
Products named: DUPIXENT, Tyvaso, NUCALA, OPSUMIT, AIRSUPRA, Arikayce, BREZTRI, WINREVAIR.
Industry payments across NC — which companies pay providers there.
